Time trends in breast cancer survival: experience in a single centre, 1975-89
1998

Trends in Breast Cancer Survival from 1975 to 1989

Sample size: 2604 publication Evidence: moderate

Author Information

Author(s): MJ Bradburn, DG Altman, P Smith, IS Fentiman, RD Rubens

Primary Institution: Guy's Hospital, London

Hypothesis

Has the survival of patients with breast cancer changed over the period 1975-89?

Conclusion

Survival rates improved for post-menopausal women with operable breast cancer diagnosed between 1985-89, likely due to increased use of tamoxifen.

Supporting Evidence

  • Survival rates for post-menopausal women improved significantly in the 1985-89 cohort compared to earlier cohorts.
  • Tamoxifen was commonly prescribed during the later years, correlating with improved survival.
  • No significant changes in survival were observed for patients with inoperable cancer.

Takeaway

This study looked at how long women with breast cancer lived from 1975 to 1989 and found that those diagnosed in the later years lived longer, especially if they were treated with a medicine called tamoxifen.

Methodology

Retrospective cohort study comparing survival rates of breast cancer patients diagnosed between 1975 and 1989, divided into cohorts based on diagnosis year.

Potential Biases

Potential bias due to the exclusion of patients with unknown menstrual status and the retrospective nature of the study.

Limitations

The study only included patients from a single center and excluded those with in situ tumors or unknown menstrual status.

Participant Demographics

The study included 2604 women diagnosed with invasive breast cancer, with a mix of premenopausal and postmenopausal patients.

Statistical Information

P-Value

<0.001

Confidence Interval

95% CI 0.51-0.78

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication